Clinical Trial Update: A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants [Phase 2, Phase 3]

View source ↗

Summary

A clinical study evaluating safety and immunogenicity of an inactivated poliomyelitis vaccine in healthy infants completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Inactivated Poliomyelitis Vaccine (inactivated poliovirus vaccine)

Snippet

Sponsor: LG Chem | Conditions: Poliomyelitis | Phase 2, Phase 3 | Status: COMPLETED